Stock PLRX PLIANT THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Official Publications Pliant Therapeutics, Inc.

Equities

PLRX

US7291391057

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-25 pm EDT 		5-day change 1st Jan Change
11.88 USD -0.17% Intraday chart for Pliant Therapeutics, Inc. -2.54% -34.40%
Mar. 12 Pliant Therapeutics, Inc. Announces Accelerated Bexotegrast Development Plan for the Treatment of Idiopathic Pulmonary Fibrosis CI
Mar. 05 RBC Lifts Price Target on Pliant Therapeutics to $54 From $50, Says Bexotegrast Could Have Multi-Billion-Dollar Revenue Opportunity; Outperform, Speculative Risk Kept MT

Official Publications

No official publication found

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies
  1. Stock Market
  2. Equities
  3. PLRX Stock
  4. News Pliant Therapeutics, Inc.
  5. Official Publications